Evolus, Inc. (EOLS) Dividend History

Evolus, Inc. (EOLS) is a medical aesthetics company specializing in products for facial aesthetic procedures. The company is best known for its flagship product, Jeuveau, a neurotoxin used to temporarily improve the appearance of fine lines and wrinkles. Evolus focuses on providing innovative solutions for practitioners and patients seeking non-invasive cosmetic treatments.

520 Newport Center Drive, Newport Beach, CA, 92660
Phone: (949) 284-4555
Website: https://www.evolus.com

Dividend History

Evolus, Inc. currently does not pay dividends

Company News

  • The article discusses the debut of Chinese boba tea chain Mixue on the Hong Kong stock exchange, the departure of Kroger's CEO due to personal conduct issues, and Domino's introduction of stuffed crust pizza. It also covers the booming med spa industry and the performance of Evolus, a competitor to Botox.

    The Motley Fool
    Featured Companies: ABBV DPZ KR
  • In our monthly Rare Stock Picks series, we're highlighting May 2024 investment picks. Click here for the list of May 2024 Buy recommendations.

    Seeking Alpha
  • The addition of Evolysse fillers to the company's portfolio complements Evolus' (EOLS) flagship neurotoxin Jeuveau.

    Zacks Investment Research
    Featured Companies: HIMS HITI MEDP
  • Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 133.8% to $1.2250 after the company requested the withdrawal of a recently filed registration statement. Also, the company announced preclinical data of its lead program PALI-2108 at the 2024 Crohn's & Colitis Congress. OneMedNet Corporation (NASDAQ: ONMD) surged 95% to $1.0401. OneMedNet announced participation as an exhibitor at the 15ᵗʰ Annual SCOPE Summit. Revelation Biosciences, Inc. (NASDAQ: REVB) shares climbed 65.8% to $16.37. Rail Vision Ltd. (NASDAQ: RVSN) gained 60% to $15.12. Connexa Sports Technologies Inc. (NASDAQ: CNXA) jumped 43% to $0.2200. Enviva Inc. (NYSE: EVA) surged 35.3% to $0.7830. Cardlytics, Inc. (NASDAQ: CDLX) surged 28% to $7.40 after the company announced it entered into a settlement agreement with SRS and updated preliminary Q4 2023 results. Lucid Group, Inc. (NASDAQ: LCID) gained 23% to $3.2703. Nyxoah S.A. (NASDAQ: NYXH) rose 22.5% to $11.53. Spectral AI, Inc. (NASDAQ: MDAI) climbed 20.2% to $3.2580 after gaining more than 35% on Friday. BTIG analyst Ryan Zimmerman recently initiated coverage on Spectral AI with a Buy rating and announced a price target of $4. SoFi Technologies, Inc. ...

    Benzinga
  • They have a kind of staying power that’s more akin to a staple than a discretionary purchase for many of their users.

    MarketWatch
    Featured Companies: ABBV EL
Page data last updated 07/23/2025 14:04:35 UTC